IDF2022-0613 PIONEER 11: Efficacy and safety of oral semaglutide versus placebo in predominantly Chinese patients with T2D treated with diet and exercise
Title:
IDF2022-0613 PIONEER 11: Efficacy and safety of oral semaglutide versus placebo in predominantly Chinese patients with T2D treated with diet and exercise
Author:
Wang, W. Chen, R. Davies, A. Lloyd Guo, J. Jensen, T. Bo Li, Y. Luo, B. Ye, X. Zhang, K. Ning, G.